Biosensor reads creatinine in seconds, enabling rapid kidney function testing with high sensitivity for faster, point-of-care ...

MediBeacon has received the CE Mark certification under the European Union (EU) Medical Device Regulation (MDR) for its ...

Basel, March 29, 2026 – Novartis today announced final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta ® (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a ...

Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, ...

One drink was the clear winner. Here’s why you should start your day with it.

Chronic kidney disease isn’t fully reversible, but early diagnosis, medical care, and lifestyle changes can slow progression, ...